Skip to content

Clinical trials

Phase 3 Renal Insufficiency, Chronic trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Renal Insufficiency, Chronic Phase: Phase 3 Country / region: United Kingdom Clear all

66 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20042
20062
20077
20082
20093
20136
20145
20152
20165
20173
20184
20194
20201
20212
20223
20232
20247
20253
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed37
Terminated12
Active, not recruiting10
Recruiting7

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca6
Tanabe Pharma Corporation6
Amgen5
Bayer4
GlaxoSmithKline4
Akebia Therapeutics3
Astellas Pharma Europe B.V.3
Boehringer Ingelheim3
Eli Lilly and Company3
Genzyme, a Sanofi Company3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Renal Insufficiency, Chronic66
Anemia15
Kidney Failure, Chronic10
Hyperphosphatemia7
Kidney Diseases7
Diabetes Mellitus, Type 25
Glomerulonephritis, IGA5
Proteinuria4
Renal Insufficiency4
Glomerulonephritis3

Trials

Showing 1 to 25 of 66. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.